A shame, since the Lancet paper has problems[1][2] in particular related to the baseline of the HCQ-treated vs non-HCQ treated patients. And by admission of the authors themselves, it is not a substitute of a RCT.
And this before the results of the Minnesota trial are out. At this point I hope those are negative, so that it does not show that countries are overreacting.
And this before the results of the Minnesota trial are out. At this point I hope those are negative, so that it does not show that countries are overreacting.
[1] https://statmodeling.stat.columbia.edu/2020/05/25/hydroxychl... and related posts
[2] https://twitter.com/StevePhillipsMD/status/12638995692528967...
PS: The title is misleading. The ban is on the use on severe diseases, not all of them, according to the text in the news.